Abbott Laboratories (ABT)
Abbott Laboratories PE Ratio: 19.22
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ABT PE Ratio Rankings
| Overall | 37th percentile | 1981 of 3184 |
| Sector | 44th percentile | 130 of 235 in Healthcare |
| Industry | 12th percentile | 14 of 16 in Drug Manufacturers - Major |
ABT PE Ratio Range, Past 5 Years
| Minimum | 13.44 | Sep 2009 |
| Maximum | 43.24 | Sep 2007 |
| Average | 19.79 |
About Price to Earnings Ratio
The price to earnings ratio (PE Ratio) is the measure of the share price relative to the annual net income earned by the firm per share. PE ratio shows current investor demand for a company share. A high PE ratio generally indicates increased demand because investors anticipate earnings growth in the future. The PE ratio has units of years, which can be interpreted as the number of years of earnings to pay back purchase price.
PE ratio is often referred to as the "multiple" because it demonstrates how much an investor is willing to pay for one dollar of earnings. PE Ratios are sometimes calculated using estimations of next year's earnings per share in the denominator. When this happens, it is usually noted.
Learn More
You may also be interested in these ABT related companies
ABT News
EBR: Watchlist/worksheet/4 Trading Ideas: $FIRE $WG $ABT $ANGI http://stks.co/3vnQ
about 4 hours ago by TheEquitiesRoom
about 4 hours ago by TheEquitiesRoom
I believe $ABT will go up in the next couple of day to a second top of a double top and then go south
about 24 hours ago by john_abot
about 24 hours ago by john_abot
Price target on $ABT is 64 but I could easily see a 3% pullback to the 50 day if market volatility keeps up. Either way long-term entry.
about 5 days ago by AlphaoverBetaTrading
about 5 days ago by AlphaoverBetaTrading
$OSUR fromwith first non-prescription HIV test buyout becomes very real $JNJ $ABT $ROG very nice price here
about 6 days ago by leahcim474
about 6 days ago by leahcim474
Listen to $ABT Abbott at Deutsche Bank AG Health Care Conference - live at 10:00 AM, ondemand after - http://stks.co/3if1
about 14 days ago by earningscast
about 14 days ago by earningscast
got mixed up, I meant $ABT in trouble because they pleaded guilty to rebranding a drug http://stks.co/3iDN
about 15 days ago by epime7heus
about 15 days ago by epime7heus
@jimcramer 's $ABT in trouble. His $COG and $CELG also still terrible recomendations. Worst in my port.
about 15 days ago by epime7heus
about 15 days ago by epime7heus
$CHK Scary day in the stock market when this is my best performing stock in my portfolio today. $CHK and $ABT are my only green.
about 19 days ago by baumusc
about 19 days ago by baumusc
$ABT http://stks.co/3ZBj closed Friday on shrinking candles & near doji at RSI 70+, will see if rests or drives higher
about 24 days ago by harmongreg
about 24 days ago by harmongreg
$VVUS halt is becuase FDA pre released and co wanted AH... might not open until monday. at 28-30 plus... $PFE $ABT wants this drug and co.
about 25 days ago by selectstock
about 25 days ago by selectstock
$ABT evening star on te daily or perhaps just a pause. No positions.
about 25 days ago by indiantraveler
about 25 days ago by indiantraveler
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ABT | 62.27 | +0.46 | +0.74% | 97.19B |
| ABR | 6.15 | +0.15 | +2.50% | 144.84M |
| ABM | 21.76 | +0.09 | +0.42% | 1.156B |
| ABH | 10.44 | -0.07 | -0.67% | 1.020B |
| ABCO | 95.99 | +0.21 | +0.22% | 1.597B |
| ABC | 36.51 | +0.43 | +1.19% | 9.303B |
| ABAX | 33.10 | -0.01 | -0.03% | 718.16M |
| AB | 13.76 | -0.01 | -0.11% | 1.449B |
| AAPL | 565.55 | +4.27 | +0.76% | 523.32B |
| AAP | 69.91 | +0.09 | +0.13% | 5.092B |
